Co-Authors
This is a "connection" page, showing publications co-authored by Maurizio Pompili and Antonio Gasbarrini.
Connection Strength
3.457
-
Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection. Gastroenterology. 2021 04; 160(5):1891-1893.
Score: 0.230
-
NAFLD or comorbidities, that is the question. J Hepatol. 2020 09; 73(3):723.
Score: 0.220
-
Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma. Ther Adv Med Oncol. 2019; 11:1758835919848184.
Score: 0.206
-
Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis. Aliment Pharmacol Ther. 2018 12; 48(11-12):1301-1311.
Score: 0.198
-
Regorafenib: a promising treatment for hepatocellular carcinoma. Expert Opin Pharmacother. 2018 Dec; 19(17):1941-1948.
Score: 0.198
-
Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018 Jul; 12(7):641-656.
Score: 0.193
-
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma. World J Hepatol. 2017 Dec 28; 9(36):1322-1331.
Score: 0.187
-
Use of Liver Imaging and Biopsy in Clinical Practice. N Engl J Med. 2017 12 07; 377(23):2295-6.
Score: 0.186
-
Rifaximin Re-treatment in Patients with Irritable Bowel Syndrome: Feels Like the First Time? Dig Dis Sci. 2017 09; 62(9):2220-2222.
Score: 0.183
-
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation. World J Gastroenterol. 2017 Jul 07; 23(25):4491-4499.
Score: 0.181
-
Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives. J Clin Transl Hepatol. 2017 Sep 28; 5(3):235-248.
Score: 0.180
-
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C. World J Hepatol. 2017 Mar 08; 9(7):352-367.
Score: 0.177
-
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports. Am J Kidney Dis. 2017 Aug; 70(2):297-300.
Score: 0.177
-
Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients. Dig Liver Dis. 2021 05; 53(5):541-544.
Score: 0.058
-
Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis. Eur Rev Med Pharmacol Sci. 2020 12; 24(24):13072-13088.
Score: 0.057
-
Sarilumab use in severe SARS-CoV-2 pneumonia. EClinicalMedicine. 2020 Oct; 27:100553.
Score: 0.057
-
Letter: liver involvement and mortality in COVID-19 patients - authors' reply. Aliment Pharmacol Ther. 2020 Oct; 52(7):1264-1265.
Score: 0.057
-
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients. Aliment Pharmacol Ther. 2020 09; 52(6):1060-1068.
Score: 0.056
-
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic. J Ultrasound. 2020 Dec; 23(4):449-456.
Score: 0.056
-
Going with the gut: probiotics as a novel therapy for hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2019 Jun; 8(3):295-297.
Score: 0.052
-
Immuno-oncology and interventional oncology: a winning combination. The latest scientific evidence. Eur Rev Med Pharmacol Sci. 2019 Jun; 23(12):5343-5350.
Score: 0.052
-
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis. J Viral Hepat. 2018 12; 25(12):1493-1500.
Score: 0.049
-
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease. Hepatology. 2019 01; 69(1):107-120.
Score: 0.049
-
The ten commandments of liver ablation: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2018 06; 22(12):3896-3904.
Score: 0.048
-
Treatment of early stage chronic hepatitis C virus infection. Expert Rev Clin Pharmacol. 2018 May; 11(5):519-524.
Score: 0.047
-
The ten commandments of chemoembolization: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2018 01; 22(2):372-381.
Score: 0.047
-
'Hug sign': a new radiological sign of intraprocedural success after combined treatment for hepatocellular carcinoma. Hepat Oncol. 2017 07; 4(3):69-73.
Score: 0.046
-
The ten commandments of hepatic radioembolization: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2017 Sep; 21(18):4014-4021.
Score: 0.046
-
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study. J Vasc Interv Radiol. 2017 Sep; 28(9):1234-1239.
Score: 0.045
-
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection. Int J Mol Sci. 2017 May 12; 18(5).
Score: 0.045
-
Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy. Eur Rev Med Pharmacol Sci. 2017 03; 21(1 Suppl):23-36.
Score: 0.044
-
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE). Radiol Med. 2013 Jun; 118(4):555-69.
Score: 0.033